Skip to main content

Crypto Financial

Bloomberg
Financial

Anthropic Pre-IPO Credit Facility to Rise Over $10 Billion

Anthropic's revolving credit facility is anticipated to rise above its approximately $10 billion target, according to sources. That's a substantial increase over a $2.5 billion five-year facility the AI company secured last year, though discussions are still ongoing. Bloomberg's Sridhar Natarajan joins Ed Ludlow with the details on "Bloomberg Tech."

Read more: Anthropic Pre-IPO Credit Facility to Rise Over $10 Billion
Bloomberg
Financial

Goldman's McClure Says IPO Market 'Wide Open' for Business

Matthew McClure, Goldman Sachs global co-head of investment, says the IPO market is "open for business," with AI-related companies accounting for more than half of capital raised despite representing about 20% of IPOs this year. Speaking with Dani Burger on "Bloomberg Deals," McClure says confidence is growing in private equity, with $1.5 trillion of capital waiting to be deployed.

Read more: Goldman's McClure Says IPO Market 'Wide Open' for Business
Bloomberg
Financial

Stocks Climb as Treasury Steps In to Support Bonds

Wall Street staged a rebound after the Treasury said it plans to boost buybacks of longer-dated bonds, a signal the US wants to lower borrowing costs after yields hit multi-decade highs. Lindsay Rosner, Head of Multi-Sector Investing at Goldman Sachs Asset Management, discusses her views on market resilience and global risk premiums.

Read more: Stocks Climb as Treasury Steps In to Support Bonds
Bloomberg
Financial

Moderna and Merck Revive mRNA Hopes With Melanoma Success

A personalized vaccine developed by Moderna Inc. and Merck & Co. reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer and showing the promise of the embattled mRNA technology. Bloomberg's Sam Fazeli joins to discuss.

Read more: Moderna and Merck Revive mRNA Hopes With Melanoma Success
Bloomberg
Financial

Harvard Fund Discloses $2.2 Billion Stake in Musk's SpaceX

Harvard Management Co. disclosed a $2.2 billion stake in SpaceX, showing how the university's endowment has profited from an early bet on Elon Musk's giant rocket company. Janet Lorin, Bloomberg News Higher Education Reporter, discusses the disclosure and what it signals for other university investments.

Read more: Harvard Fund Discloses $2.2 Billion Stake in Musk's SpaceX
Bloomberg
Financial

Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.

Read more: Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers